You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API basiliximab

✉ Email this page to a colleague

« Back to Dashboard

Detailed excipient profiles for basiliximab

Excipient focus: GLYCINE

basiliximab drug variants containing GLYCINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	basiliximab	0078-0393
>Company	>Ingredient	>NDC

basiliximab drug variants not containing GLYCINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

basiliximab drug variants containing MANNITOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	basiliximab	0078-0393
>Company	>Ingredient	>NDC

basiliximab drug variants not containing MANNITOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POTASSIUM PHOSPHATE, MONOBASIC

basiliximab drug variants containing POTASSIUM PHOSPHATE, MONOBASIC

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	basiliximab	0078-0393
>Company	>Ingredient	>NDC

basiliximab drug variants not containing POTASSIUM PHOSPHATE, MONOBASIC

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

basiliximab drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	basiliximab	0078-0393
>Company	>Ingredient	>NDC

basiliximab drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

basiliximab drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	basiliximab	0078-0393
>Company	>Ingredient	>NDC

basiliximab drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SUCROSE

basiliximab drug variants containing SUCROSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	basiliximab	0078-0393
>Company	>Ingredient	>NDC

basiliximab drug variants not containing SUCROSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.